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Abstract
Background: Researchers in the medical sciences prefer employing Cox model for survival analysis. In some cases,
however, parametric methods can provide more accurate estimates. In this study, we used Weibull model to
analyze the prognostic factors in patients with gastric cancer and compared with Cox.
Methods: We retrospectively studied 1715 patients with gastric cancer. Age at diagnosis, gender, family history,
past medical history, tumor location, tumor size, eradicative degree of surgery, depth of tumor invasion, combined
evisceration, pathologic stage, histologic grade and lymph node status were chosen as potential prognostic factors.
Weibull and Cox model were performed with hazard rate and Akaike Information Criterion (AIC) to compare the
efficiency of models.
Results: The results from both Weibull and Cox indicated that patients with the past history of having gastric
cancer had the risk of death increased significantly followed by poorly differentiated or moderately differentiated in
histologic grade. Eradicative degree of surgery, pathologic stage, depth of tumor invasion and tumor location were
also identified as independent prognostic factors found significant. Age was significant only in Weibull model.
Conclusion: From the results of multivariate analysis, the data strongly supported the Weibull can elicit more
precise results as an alternative to Cox based on AIC.
Background
Gastric carcinoma (GC) is one of the leading causes of
cancer-related death in the world [1-3], and it is the
most common malignant tumor in Asia, Eastern Europe,
and South America [4,5]. In Japan, stomach cancer
ranks the first place in women and the second place in
men with respect to the cause of death from malignant
tumor [6,7]. Although age-standardized mortality rate of
GC has decreased in China now, it is still the third most
common causes of death in men after lung and liver
cancer, and the fifth in women. For locally advanced
gastric cancer patients, the 5-year survival rate is below
20% and it is about 30% for those undergoing surgical
treatment. Even after taking curative resections, only 30-
50% of the patients can survive after 5 years [8,9]. In
terms of treatment for gastric cancer, surgery is consid-
ered as the best way for achieving good outcomes [10].
However, there are still lots of challenges for gastroin-
testinal doctors to conquer. It is estimated that at least
80% of patients recur disease even after they took cura-
tive gastric resections. Previous studies tried to find out
clinic-pathological factors and socio-demographic char-
acteristics associated with high recurrence rate. These
studies had drawn conflicting results with respect to
independent prognostic factors affecting survival of
patients with GC [1].
Parametric methods which include the exponential,
Weibull, lognormal, gamma and extreme value distribu-
tions have been widely used in fitting survival data [11].
Cox semi-parametric method [12] has also been exten-
sively used for modeling such data. These methods are
presented to account for the relationship between survi-
val and some concomitant variables such as age, gender,
family history of gastric cancer, or diagnostic character-
istics. Actually, in the medical sciences, researchers lean
to use Cox semi-parametric method instead of para-
metric methods to analyze survival data. For example,
there were studies that have been done to assess the
effect of clinic-pathological and demographic factors on
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model to find pertinent relationship between survival
time and the variables [13-15]. The primary reason is
that there seem to be fewer assumptions in the use of
Cox semi-parametric method. In some circumstances,
however, parametric methods can provide more accurate
estimates [16,17]. Many of the parametric models such
as Weibull are accelerated failure time models. Weibull
allows more flexibility than the Cox semi-parametric
model because the associated hazard rate is not constant
with respect to time. Also, we use maximum likelihood
process to estimate the unknown parameters and its
interpretation and technique are familiar for researchers.
In this study, we aimed to evaluate the potential prog-
nostic factors that may affect the survival of patients
with gastric cancer employing Weibull model, and to
compare analytic results with Cox’s proportional hazard
model.
Methods
Data Sources
We reviewed hospital database of 1,814 patients with
gastric cancer who underwent surgical treatment in
Tongji hospital in Wuhan, China, during the years 1995
to 2006. We retrospectively reviewed their medical
records and excluded 99 patients for incomplete medical
document. Finally, 1,715 patients were enrolled in our
study. Thereafter, all the patients were observed through
a programmed followed-up schedule. Survival informa-
tion was collected through telephone interviews with
patients and/or their relatives who were at home at the
time of interview. This study was approved by the Ethics
Committee of Huazhong University of Science &
Technology.
Gastric cancer stage was evaluated according to the
International Union Against Cancer (UICC) TNM classi-
fication of malignant tumors [18]. Survival analysis was
based on the clinical and pathologic variables, which
were sub-layered into family history of GC, histologic
grade (well, moderately and poorly differentiation),
tumor location (upper, middle and lower) in the stomach,
the stage of the carcinoma (I, II, III, IV), depth of tumor
penetration (T1, T2, T3, and T4) as defined by the Amer-
ican Joint Committee on Cancer (AJCC), N categories on
the basis of the number of metastatic lymph nodes (pN0:
0, pN1: 1-6, pN2: 7-15, pN3: > 15) defined by the Inter-
national Union Against Cancer (UICC) and the American
Joint Committee on Cancer (AJCC) in the 5th edition of
the TNM system in 1997 [19].
Statistical Analysis
Statistic calculations were performed using statistical
software SAS, version 9.1. Quantitative result was
expressed as the mean ± standard deviation (SD).
Univariate analysis was conducted using the Kruskal-
wallis and t test. Differences at P < 0.05 were considered
significant. Covariates that were identified as significant
factors throughout the univariate analysis were selected
for multivariate analysis, which was performed employ-
ing Weibull and Cox’s proportional hazard model to
build the prognostic indicators of survival in patients
with gastric cancer. A plot of the log of the negative log
of the estimated survivor function against log time (by
specifying LLS) was drawn. LLS plot can provide a
visual check of the appropriateness of the Weibull
model for the survival data [20]. HR (hazard rate) and
the AIC (Akaike Information Criterion) were used to
compare the efficiency of models between Weibull and
Cox model. The AIC is a measure of the goodness of fit
of the model estimated that proposed by Akaike in 1974
[21] and is a practical way of trading off the complexity
of an estimated model against how well the model fits
the data. Lower AIC indicates better likelihood.
Results
Clinical and pathologic features
Patient characteristics were detailed in Table 1. A total
number of 1715 patients with gastric cancer entered to
this study, 465(27.1%) were women and 1250(72.9%)
man. The mean age at diagnosis was 57.5 ± 10.9 years
(range = 21~90 years). Evidence of family history and
past history of GC were seen in 284 patients (16.6%) and
457 patients (26.6%) respectively. Of the total patients,
1315 patients (78.8%) had tumour size ≥40 mm, 492
patients (28.7%) diagnosed with stage IV of gastric can-
cer. Tumors were located in the lower third stomach in
1086 patients (63.3%), in the middle third of the stomach
in 281 patients (16.4%), in the upper third stomach
in 193 patients (11.3%), and whole stomach 155 patients
(9.0%). Among all the patients, 809 (47.8%) patients
received utterly eradicative degree of surgery. Tumors
were classified as well differentiated in 521 patients
(30.3%), moderately differentiated in 253 patients
(14.8%), and poorly differentiated in 941 patients (54.9%).
Lymph node involvement defined by AJCC classifications
included 629 patients with N0 category, 717 patients
with N1 category, 272 patients with N2 category, and
97 patients with N3 category. AJCC T1 about depth of
invasion was identified in 145 patients (8.5%), AJCC T2
in 879 patients (51.3%), AJCC T3 in 549 patients (32.0%),
and AJCC T4 in 142 patients (8.3%).
Distribution of the survival time
Usually, a first step in the analysis of survival data is
the estimation of the distribution of the survival time.
Figure 1 displays the graph of the log (-log (estimated
survival function)) against log (failure time), i.e. LLS
plot. If the Weibull model is appropriate, the LLS curve
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through the origin. This is because S(t) = exp(-(la t)
^alpha) holds if -log S(t) = (la t)^alpha, or if log(-log S
(t)) = alpha log(la) + alpha log t. The slope of the line in
the LLS plot is the Weibull shape parameter alpha and
the intercept is alpha log (la). In this study, the lls plot
looks approximately linear which suggests graphically
that the survival-time distribution considered is Weibull.
Moreover, the value of intercept and scale were -3.324
and 1.362, respectively, and alpha value is 0.734 given
from SAS results.
Multivariate Weibull and Cox Analysis of Prognostic
Factors
In univariate analysis, age(P < 0.001), past medical his-
tory(P = 0.022), tumor size (P < 0.001), histologic grade
(P < 0.001), tumor location(P < 0.001), eradicative
degree of surgery(P < 0.001), tumor stage (P < 0.001),
combined evisceration (P < 0.001), depth of invasion (P
< 0.001), and lymph node status (P <0 . 0 0 1 )w e r ef o u n d
significant factors that have influence on overall survival
in all gastric cancer patients who underwent surgical
treatment (Table 1). Variables shown to be of statistical
significance in univariate survival analysis were further
assessed by Weibull and Cox multivariate analysis.
According to the results from both Cox and Weibull
model patients with the past history of having gastric
cancer had the risk of death increased significantly in
term of hazard ratio in Cox regression and Weibull
model followed by poorly differentiated and moderately
differentiated in histologic grade (P <0 . 0 5 ) .E r a d i c a t i v e
degree of surgery, pathologic stage, depth of tumor inva-
sion and location of tumor were also identified as inde-
pendent prognostic factors found significant. Age is
significant in Weibull model but insignificant in Cox
model for multivariate analysis (Table 2, 3). Neither Cox
nor Weibull model in both univariate and multivariate
analysis show any evidence about significant differences
in gender and family history of cancer. In multivariate
models, the Weibull model had the best fit with respect
to lower AIC (Table 3).
Discussion
In the field of medical sciences, researchers are inter-
ested in estimating the survival model with the vector of
Table 1 Clinic-pathological characteristics of the patients
with gastric cancer
Factors Categories No. of
patients (%)
P
value
Gender Female 465(27.1) 0.301
Male 1250(72.9)
age 57.5 ± 10.9 <0.001
Past medical history No 1258(73.4) 0.022
Yes 457(26.6)
Family history of
gastric cancer
No 1431(83.4) 0.431
Yes 284(16.6)
Location of tumor Lower third 1086(63.3) <0.001
Middle third 281(16.4)
Upper third 193(11.3)
Whole stomach 155(9.03)
Eradicative degree
of surgery
Utterly 809(47.8) <0.001
Relatively 473(27.6)
Palliative 433(25.2)
Tumor size(mm) <40 364(21.2) <0.001
≥40 1315(78.8)
Stage I 301(17.5) <0.001
II 425(24.8)
III 497(29.0)
IV 492(28.7)
Combined evisceration No 1323(77.1) <0.001
Yes 392(22.9)
Histologic grade Well differentiated 521(30.3) <0.001
Moderately
differentiated
253(14.8)
Poorly
differentiated
941(54.9)
Depth of invasion T1 145(8.5) <0.001
T2 879(51.3)
T3 549(32.0)
T4 142(8.3)
Lymph node status N0 629(36.7) <0.001
N1 717(41.8)
N2 272(15.9)
N3 97(5.7)
T1, Tumour invades lamina propria or submucosa;
T2,Tumour invades muscularis propria or subserosa;
T3: Tumour penetrate serosa without invasion of adjacent structures;
T4: Tomour invades adjacent structures;
N0, Metastasis in 0 regional lymph nodes;
N1, Metastasis in 1 to 6 regional lymph nodes;
N2, Metastasis in 7 to 15 regional lymph nodes;
N3, metastasis in more than 15 regional lymph nodes.
Figure 1 Log of negative Log survivor function estimates.
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model more than parametric models. When conducting
survival analysis employing Cox model, it is necessary to
check the underlying assumptions. Cox model assumes
that changes in levels of the independent variables will
produce proportionate changes in the hazard function,
independent of time. Also, it assumes a log-linear rela-
tionship between the hazard function and the time and
a n yn u m b e ro fm e t r i ca n d / o rn o n m e t r i cv a r i a b l e s .I n
fact, however, assumptions that Cox proportional
hazards modeling required may not be plausible in
many situations [22], especially in biomedical field. If
these assumptions do not hold, the Cox model will lead
to unreliable conclusions. Unfortunately, according to
Altman’s review of survival analyses in cancer journals,
only 5 percent of all studies using the Cox model check
the underlying assumptions [23]. In the meantime, var-
ious parametric models such as Weibull and Lognormal
had been developed to analyze survival data. These
models can provide the interpretation based on specific
distributions for survival time without need the propor-
tional hazard assumptions. If survival times are Weibull
or exponentially distributed, the analysis using para-
metric methods is more powerful [16]. This means
under certain circumstances, parametric models like
Weibull, Exponential and Lognormal can elicit more
accurate results than Cox model. Since population survi-
val times are usually exponentially or Weibull distribu-
ted in the field of medicine, therefore, a parametric
model will be more efficient and easier to specify than
the corresponding semiparametric or nonparametric one
and are more flexible as it allows easy incorporation of
covariates. Several studies applying parametric models
to evaluate prognostic factors affecting survival time of
patients with cancer prove that parametric models offer
advantages over Cox model [16,24].
The purpose of this study was to explore the com-
parative performance of Weibull model and Cox model
Table 2 Multivariate analysis of Weibull parametric
model with prognostic factors
Characteristics bc
2 value P value
Intercept 0.76 0.53 0.467
Age -0.03 6.27 0.012
Past medical history -0.11 7.13 0.008
Location of tumor - 25.40 <0.001
Lower third 0.40 8.83 0.003
Middle third 0.41 7.34 0.007
Upper third -0.17 1.08 0.299
Whole stomach* 0 - -
eradicative degree of surgery - 20.62 <0.001
Utterly 1.00 83.46 <0.001
Relatively 0.91 42.27 <0.001
Palliative* 0 - -
Histologic grade - 12.51 0.002
Well differentiated -0.08 0.80 <0.001
Moderately differentiated 0.34 9.30 0.082
Poorly differentiated* 0 - -
Depth of invasion - 49.11 <0.001
T1 0.77 10.55 0.001
T2 0.22 2.48 0.115
T3 0.21 2.29 0.130
T4* 0 - -
Stage - 22.41 <0.001
I 0.62 8.27 0.004
II 0.76 21.22 <0.001
III 0.27 6.23 0.013
IV* 0 - -
*stands for a control group, and the rest compare with the control.
Table 3 Multivariate analysis of Cox and Weibull model
with prognostic factors
Characteristics Cox(AIC =
4534.21)
Weilbull(AIC =
1693.28)
HR (CI: 95%) HR (CI: 95%)
Age 1.01 (0.98-1.03) 1.03* (1.01-1.06)
Past medical history
No 1 1
Yes 1.17* (1.03-1.33) 1.22* (1.05-1.40)
Location of tumor
Lower third 1 1
Middle third 0.93 (0.74-1.18) 0.99 (0.86-1.25)
Upper third 1.47* (1.12-1.93) 1.35* (1.19-1.53)
Whole stomach 1.45* (1.08-1.93) 1.47* (1.21-1.75)
eradicative degree
of surgery
Utterly 1 1
Relatively 1.03 (0.77-1.39) 1.79*(1.64-1.92)
Palliative 2.16*(1.71-2.73) 4.07*(3.85-4.34)
Histologic grade
Well differentiated 1 1
Moderately
differentiated
1.12*(1.05-1.19) 1.14*(1.08-1.24)
Poorly differentiated 1.25*(1.18-1.33) 1.34*(1.17-1.55)
Depth of invasion
T1 1 1
T2 1.97*(1.53-2.54) 2.40*(2.10-2.53)
T3 2.19* (1.68-2.86) 2.77* (2.53-2.96)
T4 2.50*(1.82-3.44) 3.15*(3.20-3.99)
Stage
I1 1
II 0.97 (0.57-1.63) 1.15 (0.91-1.42)
III 1.57 (0.97-2.56) 1.93* (1.66-2.25)
IV 2.06* (1.21-3.51) 3.03* (2.76-3.80)
*significant at the 5% level.
HR, hazard ratio; CI, confidence interval.
AIC, akaike information criterion.
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used Akaike Information Criterion (AIC) to evaluate the
two models. In a recent review of survival analyses, it
was found that many studies have indicated clinical and
pathologic characteristics of patients as explanatory vari-
ables with respect to survival [25-27]. In this study, we
investigate the effects of age at diagnosis, gender, family
history of cancer, past medical history, location of
tumor, tumor size, eradicative degree of surgery, depth
of tumor invasion, pathologic stage, histologic grade and
lymph node status on survival time. Both Weibull and
Cox multivariate analysis showed that with the past his-
tory of having gastric cancer, patients had significantly
increased risk of death followed by the poorly differen-
tiated and moderately differentiated in histologic grade.
In addition, eradicative degree of surgery, pathologic
stage, depth of tumor invasion and location of tumor
were identified as independent prognostic factors of
patients with GC as well. In our results, gender showed
no impact on survival rate. But, some studies found that
better survival rate for women [28], another reported
that the consistently lower survival for stomach cancer
among women [6].
Age at diagnosis was a strong and independent covari-
ate for survival of patients with GC, and young patients
had better survival as indicated by previous report [29].
Tumor size is a significant factor that had impact on the
survival probability of patients in univariate analysis,
which is similar to some other studies [30,31]. Depth of
invasion was another outstanding prognostic indicator
in both univariate and multivariate analysis. Our finding
is in conformity with previous reports showed that
depth of invasion has an influence on patient’ss u r v i v a l
[32,33]. Stage at diagnosis was strongly associated with
prognosis in our study, which is a finding repeated in
several other studies [34-36]. Previous reports have
demonstrated that the number of metastatic lymph
nodes was a powerful predictor of survival. Patients with
metastases to 7 or more lymph nodes (N2, N3) had a
notably worse outcome as opposed to patients with no
lymph node metastases or metastases in 1 to 6 nodes
[1,2,37]. However, our findings are not consistent with
those previously reported showed by multivariate analy-
sis. Furthermore, our study results suggested that histo-
logical classification was an independent predictor of
survival.
In our study, age is significant in Weibull model, but
it is insignificant in Cox regression for multivariate ana-
lysis. Cox model will only be used when the hazard rate
is constant with respect to time, but from the Figure 1
in our study we can see that the survival-time distribu-
tion was Weibull distribution, so it is more accurate to
use Weibull model. The evaluation criteria also indi-
cated Weibull model to be more efficient in comparison
to Cox in multivariate analysis. The findings strongly
showed Weibull was the perfect model and might lead
to more precise results.
Conclusions
Our study showed that age at diagnosis, past medical
history, stage, eradicative degree of surgery, histologic
grade, depth of tumor invasion and location of tumor
were prognostic factors for survival in patients with GC.
It can be concluded that the early detection of patients
at younger age and in primary stages and histologic
grade may have positive effect on patients with stomach
cancer and be important to decrease the survival time.
Also, from the results of multivariate analysis, the data
strongly supported the Weibull model can elicit more
precise results as an alternative to Cox.
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